Do Patients With Colorectal Cancer Understand That Their Family is at Risk? - Full Text View

Sponsored by:	University of Chicago
Information provided by:	University of Chicago
ClinicalTrials.gov Identifier:	NCT00145860

Purpose

The purpose of this study is to assess whether patients with colorectal cancer understand that their first-degree relatives are at increased risk of getting the cancer themselves and therefore should be screened early. Among patients who do understand the risks to their family, we plan to determine who they identify as the source of their information and whether they have acted upon this information and advised family members to be screened. We hypothesize that many patients with colorectal cancer do not have a correct understanding of the risks to their first-degree relatives and the recommendations that they be screened early.

If this hypothesis is shown to be true, it can be used to direct improved and more diligent patient education. This, in turn, will hopefully increase the low screening rates among first-degree relatives, and, thereby, save lives in this high-risk population.

Condition
Colorectal Cancer

MedlinePlus related topics: Cancer Colorectal Cancer

U.S. FDA Resources

Study Type:	Observational
Study Design:	Screening, Cross-Sectional, Defined Population, Prospective Study
Official Title:	Do Patients With Colorectal Cancer Understand That Their Family is at Increased Risk?

Further study details as provided by University of Chicago:

Estimated Enrollment:	650
Study Start Date:	April 2002
Estimated Study Completion Date:	August 2005

Detailed Description:

The primary physician of patients with colorectal cancer will be contacted and asked permission to contact their patient to discuss his or her understanding of familial risk before patient is contacted.
A letter will be sent to all patients prior to being contacted, notifying them that all identifying information will be kept confidential and they may decline to participate at any time.
Patients will be called and asked a series of questions about their understanding of familial risk of colon cancer, the need for early screening and where they learned what they know. If the patient has lacking knowledge they will be educated.
Each patient will be sent informational brochures about colon cancer after the phone survey.
Six months later, the patients will be contacted again and asked a series of questions about their understanding of familial risk of colon cancer and the need for early screening to access how much impact the informational brochures had on their knowledge of cancer risk. Patients will be asked one additional demographic question about the highest level of education that they have completed.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients who were diagnosed with CRC and received first treatment here or elsewhere and patients who were diagnosed elsewhere and received their first treatment here. All are currently followed here and still alive.

Exclusion Criteria:

Patients in the registry who are not followed here, patients with Familial Adenomatous Polyposis, patients with Hereditary Non-Polyposis Colorectal Cancer, and patients with no siblings or children.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00145860

Locations

United States, Illinois
The University of Chicago
Chicago, Illinois, United States, 60637

Sponsors and Collaborators

University of Chicago

Investigators

Principal Investigator:

David Rubin, M.D.

University of Chicago

More Information

Study ID Numbers:	11589A
Study First Received:	September 1, 2005
Last Updated:	March 29, 2006
ClinicalTrials.gov Identifier:	NCT00145860
Health Authority:	United States: Institutional Review Board

Keywords provided by University of Chicago:

Colorectal Cancer

Study placed in the following topic categories:

Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Gastrointestinal Neoplasms

Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Colorectal Neoplasms

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 16, 2009